300006.SZ
Chongqing Lummy Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.09
−3.42%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−51.5x
Market Cap
CNY 5.38B
MomentumView details →
1D Return
−3.42%
YTD Return
+4.47%
RSI (14)
49.4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−51.5x
Market Cap
CNY 5.38B
RSI (14)
49.4
MomentumView details →
1D Return
−3.42%
YTD Return
+4.47%
Similar companies
Latest newsMore news →
Lemei Pharmaceutical obtained the Drug Registration Certificate for Acetylcysteine Solution for Inhalation (3ml:0.3g) approved by the National Medical Products Administration, valid until August 3, 2031, for the treatment of respiratory diseases.27d agoLummy Pharmaceutical's industrial investment fund Saifu Health plans to liquidate and dissolve.66d ago